March 14, 2026 · Form 4 insider transaction
McLeod Ian bought 1,161 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
On March 14, 2025, the Reporting Person was granted 3,484 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.